ConductScience.org, home

Trial · NCT00196196

A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.

NCT00196196, Phase 3, Completed, Codman & Shurtleff; results first posted 2008-12-05

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System. Trials, record NCT00196196. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00196196

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.
NCT number
NCT00196196
Status
Completed
Phases
Phase 3
Enrollment
274 participants, actual
Lead sponsor
Codman & Shurtleff
Conditions
Hydrocephalus, Normal Pressure Hydrocephalus
Interventions
Codman VPV System
First posted
2005-09-20
Last updated
2012-05-28
Results first posted
2008-12-05

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPercentage of Participants Who Achieved "Adjustment Complete" and a Consensus X-ray ReadingDay 1
Up to 5 attempts to achieve "Adjustment Complete" using the Codman Valve Position Verification (VPV) system for each Subject. Agreement in 2 of 3 valve X-ray readings by independent radiologists for each Subject was considered "consensus X-ray". All participants included achieved "Adjustment Complete" and a "consensus X-ray reading".
SecondaryPercentage of Agreement Between the Codman Valve Position Verification (VPV) System and Consensus X-rays Using Various ThresholdsDay 1
Percentage of agreement between consensus X-ray readings and the intended setting programmed by the Codman Valve Position Verification (VPV) system. This was assessed at various steps (intervals of mmH20) as increments allow on the Codman Hakim Programmable Valve. (1 step = 10 mmH20, 2 steps = 20 mmH20, +2 steps = \>20 mmH20)

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYPercentage of Participants Who Achieved Adjustment Complete and a Consensus X-ray ReadingDay 1Percentage of participantsNUMBER
SECONDARYPercentage of Agreement Between the Codman Valve Position Verification (VPV) System and Consensus X-rays Using Various ThresholdsDay 1Percentage of agreementNUMBER

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of Participants Who Achieved Adjustment Complete and a Consensus X-ray ReadingCodman VPV System98.33Percentage of participants
Percentage of Agreement Between the Codman Valve Position Verification (VPV) System and Consensus X-rays Using Various ThresholdsCodman VPV SystemPercentage of Agreement (exact match)63.89Percentage of agreement
Percentage of Agreement Between the Codman Valve Position Verification (VPV) System and Consensus X-rays Using Various ThresholdsCodman VPV SystemPercentage of Agreement in 1 step (+/- 10 mmH20)96.11Percentage of agreement
Percentage of Agreement Between the Codman Valve Position Verification (VPV) System and Consensus X-rays Using Various ThresholdsCodman VPV SystemPercentage of Agreement >2 steps (>20 mmH20)1.67Percentage of agreement

Participant flow3

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDCodman VPV System274
Overall StudyCOMPLETEDCodman VPV System267
Overall StudyNOT COMPLETEDCodman VPV System7

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals3

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityCodman VPV System
Total, other adverse eventsCodman VPV System00
Total, serious adverse eventsCodman VPV System00

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
9870057BACKGROUNDPubMed
10448649BACKGROUNDPubMed
10598708BACKGROUNDPubMed
10839253BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00196196

GET https://conductscience.org/api/trials/v1/NCT00196196/registered